Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Concert Pharmaceutic (NQ: CNCE )

10.75 USD -1.10 (-9.28%)
Streaming Delayed Price Updated: 12:58 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 280,133
Open 12.18
Bid (Size) 10.75 (2)
Ask (Size) 10.84 (3)
Prev. Close 11.85
Today's Range 10.71 - 12.18
52wk Range 5.470 - 13.50
Shares Outstanding 23,395,816
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
Concert will present at the Stifel Healthcare Conference and participate in a fireside chat at the Jefferies London Healthcare Conference. 
From Business Wire News Releases
Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update
Concert will host a conference call and webcast today at 8:30 a.m. ET to provide an update on the Company and discuss third quarter 2020 results. 
From Business Wire News Releases

Performance

YTD
-15.29%
-15.29%
1 Month
-13.86%
-13.86%
3 Month
-6.60%
-6.60%
6 Month
+3.46%
+3.46%
1 Year
+9.25%
+9.25%

More News

Read More
Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
From Business Wire News Releases
Concert Pharmaceuticals Presents CTP-543 Data from Long-Term Extension Study in Alopecia Areata During Late-Breaking Session at EADV Congress
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags ORGS Top Gainers DARE
From Benzinga
Concert Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020
From Business Wire News Releases
The Math Shows IEIH Can Go To $38
Tags ETFs
From ETF Channel
Concert Pharmaceuticals Announces Publication on Alopecia Areata Burden of Disease in Journal of Investigative Dermatology
From Business Wire News Releases
Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress
From Business Wire News Releases
Concert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with Schizophrenia
From Business Wire News Releases
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.